XML 89 R73.htm IDEA: XBRL DOCUMENT v3.22.0.1
Geneos Therapeutics, Inc. - Deconsolidation Accounting (Details) - USD ($)
12 Months Ended
Jun. 01, 2020
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Noncontrolling Interest [Line Items]        
Fixed assets, net of accumulated depreciation   $ (17,453,206) $ (11,348,144)  
Gain on deconsolidation of Geneos   0 (4,121,075) $ 0
Decrease in cash resulting from the deconsolidation of Geneos   $ 0 $ 2,774,851 $ 0
Geneos Therapeutics, Inc.        
Noncontrolling Interest [Line Items]        
Working capital (excluding cash) $ (59,992)      
Note payable 171,620      
Fixed assets, net of accumulated depreciation (16,340)      
Carrying value of noncontrolling interest 3,181,640      
Fair value of investment in Geneos retained 3,618,998      
Gain on deconsolidation of Geneos (4,121,075)      
Decrease in cash resulting from the deconsolidation of Geneos $ 2,774,851